Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Our working hypothesis is that the injection of autologous bone marrow mononuclear cells
(BMNC) has a positive effect on the natural loss of motor units and on the increase in the
size of the motor unit that occurs in patients with ALS during the evolution of the disease
Phase:
Phase 2
Details
Lead Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia